CUE-102/A02

N/A

Report date: 2025/01/26 17:54:59

Base Information

Drug NameCUE-102/A02
Drug Alias NameCUE-100 series (Cue Biopharma)WT-1-MHC (Cue Biopharma)WT-1(37-45)-targeted/IL-2 fusion protein (Cue Biopharma)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT-cell receptor agonistsWilms' Tumour 1 modulatorsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptorWilms' Tumour 1T-cell receptor
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCue Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical LtdCue Biopharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A